Strategic Acquisition EG Life Sciences is the product of a recent acquisition by Eliassen Group, signaling expanded scale, cross-sell opportunities across talent solutions and life sciences consulting, and potential integration to offer broader service packages.

Life Sciences Focus Specialization in medical devices, pharmaceuticals, biometrics, and diagnostics creates sales opportunities to upsell end-to-end regulatory, submissions, and compliance services aligned with FDA processes.

Regulatory Readiness Experience with FDA regulations and submissions suggests a need for ongoing quality systems, risk management, and regulatory affairs support, offering targeted services to ensure smooth product approvals and market access.

WBENC Certification Being a Women’s Business Enterprise National Council certified presents co-selling, supplier diversity, and partnership opportunities with larger organizations seeking WBENC-compliant vendors.

Growth and Reach Revenue range and 11-50 employees combined with coast-to-coast offices indicate capacity for scalable engagements, managed services, and agile consulting projects across multiple geographies and life sciences domains.